Behind every diagnostic result is a person, a family, a future bent in a better direction. The Lancet Commission estimates that nearly half the world's population has little or no access to basic testing. In India, TB patients visit a median of three healthcare providers before anyone confirms the diagnosis — losing weeks, wages, and health along the way. Access and early detection are not abstractions. They are the difference between in time and too late.
Sources: GRAM / The Lancet 2022; Lancet Commission on Diagnostics 2021; PLOS Medicine / medRxiv TB studies, India.
The human difference
Bringing trustworthy testing to the places it has never reliably reached.
A price that means a test is taken, not weighed against the week's food.
Catching what matters sooner — when it is still small enough to change.
Putting lab-grade confidence into the hands of the people already there.
What access looks like
When a clinician knows what they are treating, the patient gets the right drug, at the right dose, from the first visit. Fewer wasted antibiotics. Fewer return trips. Fewer complications from the wrong treatment.
Conditions caught early are cheaper to treat, simpler to manage, and far less likely to become life-threatening. Gestational diabetes, hypertension, anaemia, and infection risk can be acted on while action still changes the outcome.
A missed diagnosis costs health and money: repeat visits, lost wages, transport costs, and wrong treatments that do not work. A timely test at the first visit can prevent weeks of unnecessary expenditure.
Every antibiotic prescribed without a diagnostic test accelerates resistance. A test that clarifies bacterial infection and treatment direction is one of the few real levers against AMR.
When point-of-care tests generate structured data, individual results aggregate into population insight. Outbreaks are detected earlier and public-health interventions become data-driven rather than reactive.
Vision at scale
When testing becomes affordable and ubiquitous, public health stops being reactive. Outbreaks are seen sooner. Chronic disease is caught earlier. Care plans follow real data, not guesswork — across a clinic, a district, a country.
That is the scale we build for: not a better device, but a healthier population.
The measure of a diagnostic is not its precision in a lab. It is the life it changes in a village.
In practice
A health worker runs a check during the visit — no sample sent away, no second trip for a family that can't easily make one.
Quiet, continuous awareness at home means concerns are noticed before they become emergencies.
Frontline workers gain lab-grade certainty in the places that need it most — without the lab.